| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 7 | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | - | - |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 101 |
| 17 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 1,011 |
| 598 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| PLP(L) | 434 | 35.3% | -0.84 | 242 | 37.9% |
| CentralBrain-unspecified | 296 | 24.1% | -0.91 | 157 | 24.6% |
| CA(L) | 178 | 14.5% | -0.40 | 135 | 21.2% |
| Optic-unspecified(L) | 110 | 9.0% | -2.26 | 23 | 3.6% |
| AME(L) | 101 | 8.2% | -2.57 | 17 | 2.7% |
| SLP(L) | 55 | 4.5% | -0.36 | 43 | 6.7% |
| SCL(L) | 34 | 2.8% | -1.00 | 17 | 2.7% |
| LH(L) | 5 | 0.4% | -0.32 | 4 | 0.6% |
| ME(L) | 7 | 0.6% | -inf | 0 | 0.0% |
| SMP(L) | 6 | 0.5% | -inf | 0 | 0.0% |
| ICL(L) | 3 | 0.2% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns aMe23 | % In | CV |
|---|---|---|---|---|---|
| VP1m+VP2_lvPN2 (L) | 4 | ACh | 215 | 18.6% | 0.5 |
| aMe5 (L) | 25 | ACh | 185 | 16.0% | 0.8 |
| aMe12 (L) | 4 | ACh | 123 | 10.6% | 0.1 |
| aMe2 (L) | 4 | Glu | 87 | 7.5% | 0.4 |
| VP3+_vPN (L) | 1 | GABA | 86 | 7.4% | 0.0 |
| MeVP15 (L) | 12 | ACh | 42 | 3.6% | 0.4 |
| VP2_adPN (L) | 1 | ACh | 40 | 3.5% | 0.0 |
| aMe9 (L) | 2 | ACh | 31 | 2.7% | 0.2 |
| aMe9 (R) | 2 | ACh | 28 | 2.4% | 0.2 |
| aMe12 (R) | 2 | ACh | 27 | 2.3% | 0.4 |
| LHPV6k2 (L) | 2 | Glu | 19 | 1.6% | 0.1 |
| SLP184 (L) | 1 | ACh | 18 | 1.6% | 0.0 |
| VP2+_adPN (L) | 1 | ACh | 11 | 0.9% | 0.0 |
| aMe6b (L) | 1 | ACh | 10 | 0.9% | 0.0 |
| LoVP96 (L) | 1 | Glu | 10 | 0.9% | 0.0 |
| aMe10 (R) | 2 | ACh | 10 | 0.9% | 0.6 |
| VP1m+VP2_lvPN1 (L) | 1 | ACh | 9 | 0.8% | 0.0 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 9 | 0.8% | 0.0 |
| MeVP38 (L) | 1 | ACh | 9 | 0.8% | 0.0 |
| 5thsLNv_LNd6 (L) | 1 | ACh | 8 | 0.7% | 0.0 |
| OA-AL2i3 (L) | 2 | OA | 8 | 0.7% | 0.5 |
| MeVP21 (L) | 2 | ACh | 8 | 0.7% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 7 | 0.6% | 0.0 |
| LHPV6f5 (L) | 2 | ACh | 7 | 0.6% | 0.7 |
| MeVP14 (L) | 4 | ACh | 7 | 0.6% | 0.5 |
| MeLo1 (L) | 5 | ACh | 7 | 0.6% | 0.3 |
| SLP412_a (L) | 1 | Glu | 6 | 0.5% | 0.0 |
| MeVP31 (L) | 1 | ACh | 6 | 0.5% | 0.0 |
| SLP460 (L) | 1 | Glu | 6 | 0.5% | 0.0 |
| aMe17a (L) | 1 | unc | 5 | 0.4% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 5 | 0.4% | 0.0 |
| aMe22 (L) | 1 | Glu | 4 | 0.3% | 0.0 |
| aMe10 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| LHAV3p1 (L) | 1 | Glu | 4 | 0.3% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 4 | 0.3% | 0.0 |
| LHPV6j1 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| aMe8 (L) | 2 | unc | 4 | 0.3% | 0.5 |
| MeVP5 (L) | 3 | ACh | 4 | 0.3% | 0.4 |
| LHPV4c1_a (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| aMe13 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| LHPV4m1 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| CSD (R) | 1 | 5-HT | 3 | 0.3% | 0.0 |
| aMe4 (L) | 2 | ACh | 3 | 0.3% | 0.3 |
| SLP457 (L) | 2 | unc | 3 | 0.3% | 0.3 |
| aMe26 (L) | 3 | ACh | 3 | 0.3% | 0.0 |
| CB1976 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| SLP435 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| SLP210 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| MeVP3 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| aMe1 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| LHPV2h1 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 2 | 0.2% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 2 | 0.2% | 0.0 |
| DN1a (L) | 2 | Glu | 2 | 0.2% | 0.0 |
| MeVPLo2 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| aMe6c (L) | 2 | Glu | 2 | 0.2% | 0.0 |
| MeVP16 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB3173 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV6h1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| KCg-d (L) | 1 | DA | 1 | 0.1% | 0.0 |
| CB1901 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_lPNm13 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB4158 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| DNES2 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LHPV4c1_b (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP082 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV4c1_c (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP421 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP4 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP39 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| VP2+Z_lvPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL086_b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP123 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP075 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| aMe24 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP249 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VP4_vPN (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| Lat2 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LPN_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP247 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| WED092 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe3 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP25 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| WEDPN12 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPMe6 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP23 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP53 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPMe11 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| DA4m_adPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP47 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns aMe23 | % Out | CV |
|---|---|---|---|---|---|
| LHAV3q1 (L) | 1 | ACh | 113 | 9.5% | 0.0 |
| VP2_adPN (L) | 1 | ACh | 75 | 6.3% | 0.0 |
| aMe12 (L) | 4 | ACh | 72 | 6.1% | 0.3 |
| VP1m+VP2_lvPN2 (L) | 4 | ACh | 67 | 5.6% | 0.4 |
| SLP267 (L) | 4 | Glu | 52 | 4.4% | 0.3 |
| MeVP14 (L) | 11 | ACh | 50 | 4.2% | 0.8 |
| 5thsLNv_LNd6 (L) | 2 | ACh | 49 | 4.1% | 0.3 |
| SLP266 (L) | 3 | Glu | 37 | 3.1% | 0.7 |
| LHPV6f1 (L) | 5 | ACh | 34 | 2.9% | 0.6 |
| aMe4 (L) | 9 | ACh | 33 | 2.8% | 0.7 |
| aMe6b (L) | 1 | ACh | 25 | 2.1% | 0.0 |
| LHPV8c1 (L) | 1 | ACh | 22 | 1.9% | 0.0 |
| LHPV6h1 (L) | 3 | ACh | 21 | 1.8% | 0.6 |
| SMP192 (L) | 1 | ACh | 19 | 1.6% | 0.0 |
| LHPV4c1_b (L) | 4 | Glu | 19 | 1.6% | 0.7 |
| SLP066 (L) | 1 | Glu | 17 | 1.4% | 0.0 |
| CB2555 (L) | 1 | ACh | 15 | 1.3% | 0.0 |
| LHPV4c1_a (L) | 1 | Glu | 15 | 1.3% | 0.0 |
| SLP184 (L) | 1 | ACh | 14 | 1.2% | 0.0 |
| aMe26 (L) | 3 | ACh | 14 | 1.2% | 0.7 |
| aMe12 (R) | 2 | ACh | 13 | 1.1% | 0.2 |
| SMP232 (L) | 1 | Glu | 12 | 1.0% | 0.0 |
| VM6_adPN (L) | 1 | ACh | 12 | 1.0% | 0.0 |
| aMe2 (L) | 3 | Glu | 12 | 1.0% | 0.5 |
| VP1m+VP2_lvPN1 (L) | 1 | ACh | 10 | 0.8% | 0.0 |
| LHPV2a1_a (L) | 2 | GABA | 10 | 0.8% | 0.8 |
| CB4112 (L) | 3 | Glu | 10 | 0.8% | 0.8 |
| LHCENT4 (L) | 1 | Glu | 9 | 0.8% | 0.0 |
| SLP402_a (L) | 2 | Glu | 9 | 0.8% | 0.3 |
| aMe1 (L) | 2 | GABA | 9 | 0.8% | 0.3 |
| OA-AL2i3 (L) | 2 | OA | 9 | 0.8% | 0.3 |
| MeVP39 (L) | 1 | GABA | 8 | 0.7% | 0.0 |
| CL356 (L) | 2 | ACh | 8 | 0.7% | 0.5 |
| DN1a (L) | 2 | Glu | 8 | 0.7% | 0.0 |
| aMe5 (L) | 6 | ACh | 8 | 0.7% | 0.4 |
| SLP210 (L) | 1 | ACh | 7 | 0.6% | 0.0 |
| SLP368 (R) | 1 | ACh | 7 | 0.6% | 0.0 |
| SLP074 (L) | 1 | ACh | 7 | 0.6% | 0.0 |
| LHAV3p1 (L) | 1 | Glu | 7 | 0.6% | 0.0 |
| LHPD5a1 (L) | 1 | Glu | 7 | 0.6% | 0.0 |
| ATL020 (L) | 2 | ACh | 7 | 0.6% | 0.1 |
| SMP421 (L) | 1 | ACh | 6 | 0.5% | 0.0 |
| PPL202 (L) | 1 | DA | 6 | 0.5% | 0.0 |
| LHPV6k2 (L) | 2 | Glu | 6 | 0.5% | 0.7 |
| SMP229 (L) | 3 | Glu | 6 | 0.5% | 0.7 |
| VP1m+_lvPN (L) | 2 | Glu | 6 | 0.5% | 0.3 |
| WED092 (L) | 3 | ACh | 6 | 0.5% | 0.4 |
| CL352 (L) | 1 | Glu | 5 | 0.4% | 0.0 |
| VM4_adPN (L) | 1 | ACh | 5 | 0.4% | 0.0 |
| DA4m_adPN (L) | 1 | ACh | 5 | 0.4% | 0.0 |
| PVLP093 (L) | 1 | GABA | 5 | 0.4% | 0.0 |
| LHPV4c1_c (L) | 3 | Glu | 5 | 0.4% | 0.3 |
| LHPV5b2 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| SMP257 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| SMP239 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| PS272 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| SMP183 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| WEDPN12 (L) | 1 | Glu | 4 | 0.3% | 0.0 |
| MeVP28 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| SLP295 (L) | 2 | Glu | 4 | 0.3% | 0.5 |
| MeVP15 (L) | 4 | ACh | 4 | 0.3% | 0.0 |
| SLP080 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| aMe8 (L) | 1 | unc | 3 | 0.3% | 0.0 |
| LT43 (L) | 1 | GABA | 3 | 0.3% | 0.0 |
| LoVP82 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| KCg-s2 (L) | 1 | DA | 3 | 0.3% | 0.0 |
| LHPV2a1_e (L) | 1 | GABA | 3 | 0.3% | 0.0 |
| aMe13 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| LHAV3f1 (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| KCa'b'-ap1 (L) | 3 | DA | 3 | 0.3% | 0.0 |
| CB1976 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LHPV4a2 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| CB3013 (L) | 1 | unc | 2 | 0.2% | 0.0 |
| aMe22 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| SMP142 (L) | 1 | unc | 2 | 0.2% | 0.0 |
| SLP412_b (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LHPV5m1 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| SLP171 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| PLP231 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| CL083 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| SLP368 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| aMe10 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| CL327 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| aMe10 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LHAV3e1 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| PPL203 (L) | 1 | unc | 2 | 0.2% | 0.0 |
| LoVP96 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| DNpe021 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| MeVP29 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| CSD (R) | 1 | 5-HT | 2 | 0.2% | 0.0 |
| aMe17a (L) | 1 | unc | 2 | 0.2% | 0.0 |
| SLP324 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| CB4119 (L) | 2 | Glu | 2 | 0.2% | 0.0 |
| SLP249 (L) | 2 | Glu | 2 | 0.2% | 0.0 |
| CB4208 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP425 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHAV4i1 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVC20 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHAV3e4_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP358 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP134 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV5h4 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPD2a6 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB0943 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPD2b1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP331 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| WED093 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP243 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP402_b (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV4c3 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP160 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHPV4c2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP124 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_lvPNm48 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP322 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| KCg-d (L) | 1 | DA | 1 | 0.1% | 0.0 |
| KCg (L) | 1 | DA | 1 | 0.1% | 0.0 |
| PLP145 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP360_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1782 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP365 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP316 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MB-C1 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHAV2g3 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP345 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB1984 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| AVLP470_b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| DNpe053 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP531 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VP2+Z_lvPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPD2d1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP235 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP21 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe24 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV6m1 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe6c (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe9 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP247 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| WED092 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC21 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| FB8B (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP250 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP33 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VP5+Z_adPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe20 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP457 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LHPV5i1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP211 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| DNpe043 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| APL (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| AVLP571 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL063 (L) | 1 | GABA | 1 | 0.1% | 0.0 |